Cargando…

PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer

BACKGROUND: Prostate Stem Cell Antigen (PSCA) is frequently expressed in prostate cancer but its exact function is unclear. METHODS: To clarify contradictory findings on the prognostic role of PSCA expression, a tissue microarray containing 13,665 prostate cancers was analyzed by immunohistochemistr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heinrich, Marie-Christine, Göbel, Cosima, Kluth, Martina, Bernreuther, Christian, Sauer, Charlotte, Schroeder, Cornelia, Möller-Koop, Christina, Hube-Magg, Claudia, Lebok, Patrick, Burandt, Eike, Sauter, Guido, Simon, Ronald, Huland, Hartwig, Graefen, Markus, Heinzer, Hans, Schlomm, Thorsten, Heumann, Asmus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984312/ https://www.ncbi.nlm.nih.gov/pubmed/29855276 http://dx.doi.org/10.1186/s12885-018-4547-7

Ejemplares similares

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
por: Minner, Sarah, et al.
Publicado: (2019)

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer
por: Heumann, Asmus, et al.
Publicado: (2018)

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer
por: Weidemann, Sören A., et al.
Publicado: (2019)

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues
por: Bonk, Sarah, et al.
Publicado: (2019)

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
por: Burdelski, Christoph, et al.
Publicado: (2015)

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer
por: Burdelski, Christoph, et al.
Publicado: (2015)

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
por: Luebke, Andreas M., et al.
Publicado: (2019)

Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer
por: Marx, Andreas, et al.
Publicado: (2020)

Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer
por: Steurer, Stefan, et al.
Publicado: (2019)

Upregulation of centromere protein F is linked to aggressive prostate cancers
por: Göbel, Cosima, et al.
Publicado: (2018)

VEGFR-1 Overexpression Identifies a Small Subgroup of Aggressive Prostate Cancers in Patients Treated by Prostatectomy
por: Tsourlakis, Maria Christina, et al.
Publicado: (2015)

Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer
por: Marx, Andreas, et al.
Publicado: (2021)

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases
por: Brandi, Franziska, et al.
Publicado: (2018)

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer
por: Schroeder, Cornelia, et al.
Publicado: (2019)

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
por: Zabalza, Cristina Villares, et al.
Publicado: (2015)

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients
por: Büscheck, Franziska, et al.
Publicado: (2020)

SNW1 is a prognostic biomarker in prostate cancer
por: Höflmayer, Doris, et al.
Publicado: (2019)

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion
por: Fraune, Christoph, et al.
Publicado: (2020)

Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers
por: Marx, Andreas, et al.
Publicado: (2020)

Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion
por: Steurer, Stefan, et al.
Publicado: (2019)

Deletion of 18q is a strong and independent prognostic feature in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2016)

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2015)

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2017)

Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions
por: Bernreuther, Christian, et al.
Publicado: (2020)

Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer
por: Höflmayer, Doris, et al.
Publicado: (2019)

Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer
por: Freytag, Morton, et al.
Publicado: (2020)

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma
por: Eichenauer, Till, et al.
Publicado: (2020)

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
por: Burdelski, Christoph, et al.
Publicado: (2015)

Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy
por: Schroeder, Cornelia, et al.
Publicado: (2019)

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer
por: Eichenauer, Till, et al.
Publicado: (2019)

Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence
por: Kind, Simon, et al.
Publicado: (2020)

Upregulation of SPDEF is associated with poor prognosis in prostate cancer
por: Meiners, Jan, et al.
Publicado: (2019)

Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers
por: Möller, Katharina, et al.
Publicado: (2020)

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer
por: Melling, Nathaniel, et al.
Publicado: (2015)

Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer
por: Kluth, Martina, et al.
Publicado: (2018)

Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2017)

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer
por: Melling, Nathaniel, et al.
Publicado: (2017)

Diagnostic Efficacy of PSMA and PSCA mRNAs Combined to PSA in Prostate Cancer Patients
por: Mahmoud, Mustafa M, et al.
Publicado: (2023)

Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors
por: Menz, Anne, et al.
Publicado: (2022)

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
por: Lotan, Tamara L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vgse0riegivr3db4qaarqngrjt